Hassan Safer-Tebbi (Siemens Healthcare France): ''Our investments in R&D, about 8% of revenue, translated into four patents file

Hassan Safer-Tebbi, Managing Director & CEO, Siemens Healthcare France, shares his perspective on innovation in healthcare industry.

Publicado Tuesday, August 9th 2016
Hassan Safer-Tebbi (Siemens Healthcare France): ''Our investments in R&D, about 8% of revenue, translated into four patents file

 

Leaders League. What impact has the development of e-health had on your business?

 

Hassan Safer-Tebbi. E-health is the digitalization of key processes. It corresponds to the emergence of technology and strong societal expectations of economic efficiency and decompartmentalization of healthcare pathways. For industrials, technical frameworks of system interoperability are set by the State, and infrastructure ranges from big data to small image compression software within this canvas. At Siemens, we offer cross-spectrum solutions. One of the major issues is instant access to distance information, as with tele-radiology. At the other end of the prism, our collaborative system Teamplay is based on the considerable quantity of data collected by our equipment to facilitate decision making. Thanks to a great number of benchmarks, health professionals can better optimize prescribed care depending on situations. Site productivity can therefore be evaluated on tangible elements, and areas for improvement emerge quickly.

 

Leaders League. How do you view the emergence of new competition in your industry?

 

H. S.-T. I have an interested but calm view of these new actors. Of course, they arouse my interest due to their competing offers; however, these firms are often positioned on other segments such as the Quantified Self. For years, our competitive landscape was wide, especially in our in-vitro activities and imaging. As to the above-mentioned calmness, it comes from our "Siemens Touch" that characterizes our offers on the market. Our investments in R&D, at about 8% of revenues, translate into 4 patents filed per day. Apart from collaborating with the best research sites around the world, some M&A operations are also expected in the mid-term.

 

Translated from the French article of Thomas Bastin by Jeanne Yizhen Yin